The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a ...

Among the most significant projects is Novartis' decision to build a new production facility for radioligand therapies in Halle (Saale). The technology is considered groundbreaking in personalized ...

Conclusions: Two-stage HRSN screening based on geography is suboptimal. Although a 2-stage approach based on area-level socioeconomic measures can reduce the number of patients requiring ...